Cite
HARVARD Citation
Singh, K. et al. (2021). M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia. International journal of cancer. 148 (9), pp. 2335-2344. [Online].